Page last updated: 2024-08-23

raloxifene hydrochloride and Brain Vascular Disorders

raloxifene hydrochloride has been researched along with Brain Vascular Disorders in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blackwell, T; Cummings, SR; Ensrud, KE; Ishani, A; Slinin, Y	1
Cauley, JA; Johnell, O; Kulkarni, PM; Stock, JL; Wong, M	1
Barrett-Connor, E; Cox, DA; Dowsett, SA; Ensrud, K; Geiger, MJ; Genazzani, AR; McNabb, M	1

Trials

2 trial(s) available for raloxifene hydrochloride and Brain Vascular Disorders

Article	Year
Raloxifene reduces risk of vertebral fractures [corrected] in postmenopausal women regardless of prior hormone therapy. The Journal of family practice, 2004, Volume: 53, Issue:10 Topics: Adult; Aged; Bone Density; Breast Neoplasms; Cardiovascular Diseases; Cerebrovascular Disorders; Estrogen Replacement Therapy; Female; Humans; Logistic Models; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Spinal Fractures	2004
Effect of raloxifene on cardiovascular adverse events in postmenopausal women with osteoporosis. The American journal of cardiology, 2006, Feb-15, Volume: 97, Issue:4 Topics: Aged; Bone Density Conservation Agents; Breast Neoplasms; Cerebrovascular Disorders; Coronary Disease; Female; Follow-Up Studies; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride	2006

Article

Year

Raloxifene reduces risk of vertebral fractures [corrected] in postmenopausal women regardless of prior hormone therapy.

The Journal of family practice, 2004, Volume: 53, Issue:10

Topics: Adult; Aged; Bone Density; Breast Neoplasms; Cardiovascular Diseases; Cerebrovascular Disorders; Estrogen Replacement Therapy; Female; Humans; Logistic Models; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Spinal Fractures

2004

Effect of raloxifene on cardiovascular adverse events in postmenopausal women with osteoporosis.

The American journal of cardiology, 2006, Feb-15, Volume: 97, Issue:4

Topics: Aged; Bone Density Conservation Agents; Breast Neoplasms; Cerebrovascular Disorders; Coronary Disease; Female; Follow-Up Studies; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride

2006

Other Studies

2 other study(ies) available for raloxifene hydrochloride and Brain Vascular Disorders

Article	Year
Serum calcium, phosphorus and cardiovascular events in post-menopausal women. International journal of cardiology, 2011, Jun-16, Volume: 149, Issue:3 Topics: Aged; Biomarkers; Bone Density Conservation Agents; Calcium; Cerebrovascular Disorders; Coronary Disease; Female; Follow-Up Studies; Humans; Incidence; Middle Aged; Multicenter Studies as Topic; Osteoporosis; Phosphorus; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors	2011
Tamoxifen for prevention of breast cancer. The Medical letter on drugs and therapeutics, 1999, Jan-01, Volume: 41, Issue:1043 Topics: Adult; Breast Neoplasms; Cerebrovascular Disorders; Drug Costs; Endometrial Neoplasms; Estrogen Antagonists; Estrogens; Female; Fractures, Bone; Humans; Middle Aged; Myocardial Infarction; Osteoporosis, Postmenopausal; Piperidines; Placebos; Pulmonary Embolism; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Tamoxifen; Thrombophlebitis	1999

Article

Year

Serum calcium, phosphorus and cardiovascular events in post-menopausal women.

International journal of cardiology, 2011, Jun-16, Volume: 149, Issue:3

Topics: Aged; Biomarkers; Bone Density Conservation Agents; Calcium; Cerebrovascular Disorders; Coronary Disease; Female; Follow-Up Studies; Humans; Incidence; Middle Aged; Multicenter Studies as Topic; Osteoporosis; Phosphorus; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors

2011

Tamoxifen for prevention of breast cancer.

The Medical letter on drugs and therapeutics, 1999, Jan-01, Volume: 41, Issue:1043

Topics: Adult; Breast Neoplasms; Cerebrovascular Disorders; Drug Costs; Endometrial Neoplasms; Estrogen Antagonists; Estrogens; Female; Fractures, Bone; Humans; Middle Aged; Myocardial Infarction; Osteoporosis, Postmenopausal; Piperidines; Placebos; Pulmonary Embolism; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Tamoxifen; Thrombophlebitis

1999